Breakthrough T1D Blog

Hamilton, ON, Canada and New York, NY – On October 3, 2023, Allarta Life Science, a Hamilton, Ontario-based regenerative medicine company announced it has received an award from JDRF International (JDRF Canada’s parent organization), that could amount to US$800,000 upon completion of research and development milestones. Allarta was co-founded in 2019 by McMaster University Chemistry […]

Semaglutide, brand names Ozempic®, Rybelsus®, and Wegovy®, is all over the news. It is Health Canada-approved to help people with type 2 diabetes (T2D) manage their blood glucose levels. It also decreases the risk of cardiovascular events and helps with weight loss. According to a recent commentary published in the New England Journal of Medicine […]

The JDRF Canada Emerging Clinician Research Award (ECRA) is designed to provide crucial support to investigators who plan to pursue a career in type 1 diabetes (T1D)-related clinical investigation. Awards are made in the late stage of training or early career to support the development of the awardee’s independent research program.   These awards are […]

50% of profits go to JDRF Warrior Hill was founded by a family with both a parent and child who live with type 1 diabetes (T1D) who have a passion for sports and a commitment to helping people with diabetes perform their best. When Lisa and Aaron Hill’s (who lives with T1D himself) son Luke […]

A significant part of JDRF Canada funding goes towards supporting cure-based research for type 1 diabetes (T1D). One such pathway is via stem cell replacement therapies that replace the beta cells responsible for producing insulin killed in the autoimmune process during T1D. The goal is to implant new beta cells that can one day start […]